|
gptkbp:instanceOf
|
gptkb:organization
|
|
gptkbp:abbreviation
|
gptkb:ICH
|
|
gptkbp:category
|
gptkb:International_Standard
gptkb:drug
healthcare
|
|
gptkbp:focus
|
safety
efficacy
multidisciplinary guidelines
pharmaceutical quality
|
|
gptkbp:founded
|
1990
|
|
gptkbp:fullName
|
gptkb:International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use
|
|
gptkbp:governingBody
|
gptkb:ICH_Assembly
|
|
gptkbp:headquartersLocation
|
gptkb:Geneva,_Switzerland
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
ICH
|
|
gptkbp:language
|
English
|
|
gptkbp:member
|
gptkb:Swissmedic
gptkb:European_Union
gptkb:World_Health_Organization
gptkb:Ministry_of_Health,_Labour_and_Welfare_(Japan)
gptkb:Health_Canada
gptkb:Therapeutic_Goods_Administration_(Australia)
gptkb:United_States_Food_and_Drug_Administration
gptkb:Brazilian_Health_Regulatory_Agency
gptkb:China_National_Medical_Products_Administration
gptkb:Korea_Ministry_of_Food_and_Drug_Safety
gptkb:Pharmaceuticals_and_Medical_Devices_Agency_(Japan)
|
|
gptkbp:notableGuideline
|
gptkb:ICH_E6_Good_Clinical_Practice
gptkb:ICH_M4_Common_Technical_Document
gptkb:ICH_Q3A_Impurities_in_New_Drug_Substances
gptkb:ICH_Q7_Good_Manufacturing_Practice
gptkb:ICH_S6_Preclinical_Safety_Evaluation_of_Biotechnology-Derived_Pharmaceuticals
|
|
gptkbp:purpose
|
harmonization of pharmaceutical regulations
|
|
gptkbp:regionServed
|
global
|
|
gptkbp:relatedOrganization
|
gptkb:International_Federation_of_Pharmaceutical_Manufacturers_&_Associations
gptkb:International_Pharmaceutical_Regulators_Programme
|
|
gptkbp:secretariat
|
gptkb:ICH_Secretariat
|
|
gptkbp:type
|
gptkb:nonprofit_organization
|
|
gptkbp:website
|
https://www.ich.org/
|
|
gptkbp:bfsParent
|
gptkb:UCL_Institute_of_Child_Health
|
|
gptkbp:bfsLayer
|
5
|